BioSpace News Archive

Medical applications of 3D printing—including medical and dental implants, additive manufacturing (AM)-enabled tissue fabrication, patient-matched models and surgical guides, and prosthetics and assistive devices—are expanding rapidly.

Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today reports its financial results and provides an update on its operational progress for the first quarter ended 30 April 2019.

Auditory Steady-State Response (ASSR) is a translational EEG biomarker of the brain’s ability to process sensory information. 40Hz ASSR responses are specifically lowered in patients and rodent models of schizophrenia, making it relevant to evaluate antipsychotic drugs potential.

RxFunction, Inc. has announced the market launch of Walkasins®, a wearable lower limb sensory neuroprosthesis that helps improve balance and gait in patients who experience balance problems due to sensory peripheral neuropathy.

Peli BioThermal, the global name in temperature-controlled packaging, announces the opening of a new network station and service centre in Mexico City, Mexico. Mexico is the second largest pharmaceutical market in Latin America — and 12th in the world — with more than $1.75 billion in pharmaceutical exports since 2015.

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that it will co-support a satellite symposium around current and emerging treatment options for Acute Myeloid Leukemia (AML) at the 24th European Hematology Association (EHA) Congress.

Utah Valley Hospital (Provo, Utah) has installed nine Carestream imaging systems that equip its radiology staff to deliver rapid, high-quality imaging throughout the 395-bed facility.

CARTANA AB, Lunaphore Technologies S.A, and Prof. Dr. Mats Nilsson’s laboratory at Science for Life laboratory, Stockholm University, announce a collaboration on the integration and automation of CARTANA’s Next Generation In Situ Sequencing (NGISS) on Lunaphore’s microfluidic tissue processor technology.

As part of its ongoing mission to advocate for researchers in the genomics age, Integrated DNA Technologies (IDT) will unveil the latest additions to its NGS catalogue to the European market at the European Human Genetics (ESHG) Conference in Gothenburg, Sweden on 15–18 June, 2019.

Samsung Bioepis Co., Ltd. today announced that its anti-TNF biosimilars portfolio will be the subject of nine presentations at the Annual European Congress of Rheumatology (EULAR 2019) in Madrid, Spain (June 12–15).